Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 404173 in obese type 2 diabetes
NCT01918865Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 3
01
Overview
A Phase 2 trial of IONIS PTP1BRx in type 2 diabetes mellitus (T2DM), sponsored by Ionis Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
IONIS PTP1BRx
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01918865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918865.